The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

According to The Business Research Company’s Sacral Nerve Stimulation Devices Global Market Report 2024, the sacral nerve stimulation devices market is expected to show promising growth in the forecast period.

The sacral nerve stimulation devices market has seen significant expansion, driven by technological advancements and increasing awareness of non-invasive treatment options. Here’s an overview of the market’s recent growth, upcoming trends, and key factors driving the industry forward.

Market Growth Overview

• Current Market Size: The sacral nerve stimulation devices market was valued at $1.19 billion in 2023.
• Projected Growth: By 2024, the market is expected to reach $1.33 billion, growing at a CAGR of 11.6%. The market is projected to reach $2.08 billion by 2028, with a slightly higher CAGR of 11.7%.
• Key Drivers: This growth can be attributed to:
  • Rising prevalence of urinary and fecal incontinence.
  • Technological advancements in neuromodulation.
  • Increased awareness of non-surgical treatment options.
  • Favorable reimbursement policies.
  • Growing geriatric population and higher incidences of neurological disorders.
  • Increased healthcare spending.

View More On The Sacral Nerve Stimulation Devices Market Report 2024 – https://www.thebusinessresearchcompany.com/report/sacral-nerve-stimulation-devices-global-market-report 

Key Trends Shaping the Future

Several major trends are expected to further propel the growth of the sacral nerve stimulation devices market:

• Miniaturization and Implantable Technologies: Advances in implantable devices are driving innovation, making treatments more comfortable for patients.
• Development of External SNS Devices: Companies are exploring non-invasive external devices to meet patient preferences for less invasive treatments.
• Regulatory Advances: Favorable regulatory environments are making it easier for new devices to enter the market.
• Increasing Awareness: Patient education on sacral nerve stimulation and other non-surgical options continues to grow.

Increasing Prevalence of Urological Disorders

Urological disorders, which range from urinary tract infections to chronic kidney disease, are becoming more common and contribute significantly to the growth of the sacral nerve stimulation market.

• Contributing Factors: Causes of urological disorders include aging, poor diet, dehydration, and lifestyle factors like lack of exercise.
• Managing Urological Conditions: Sacral nerve stimulation devices provide a minimally invasive option to treat these conditions effectively.
• Prevalence Data: In 2024, according to the National Institute of Diabetes and Digestive and Kidney Diseases, over 651,000 individuals aged 65 and older were diagnosed with urinary incontinence, underscoring the need for advanced treatments like sacral nerve stimulation.

Technological Advancements Driving Innovation

Major companies in the sacral nerve stimulation devices market are introducing cutting-edge products to enhance patient outcomes and reduce side effects.

• Next-Generation Devices: Innovations such as Medtronic’s InterStim X, launched in 2022, provide long-term, recharge-free treatment for conditions like overactive bladder and chronic fecal incontinence. The device offers personalized treatment for up to a decade, significantly improving patient compliance.

Key Players in the Market

The market is home to several prominent players focusing on innovation and improving patient outcomes:

• Key Companies:
  • Abbott
  • Medtronic plc
  • Boston Scientific Corporation
  • Axonics Modulation Technologies
  • Laborie Medical Technologies
  • Beijing PINS Medical Co. Ltd.
  • Nevro Corp.
  • Cala Health

These companies are driving the development of next-generation sacral neuromodulation devices and other solutions to address the growing demand for non-invasive treatments.

Market Segmentation and Regional Insights

The sacral nerve stimulation devices market can be segmented by type, product, age, application, and end user:

• By Type: Electrical Muscle Stimulation, Transcutaneous Electrical Nerve Stimulation
• By Product: External SNS Devices, Implantable SNS Devices
• By Age: Pediatrics, Adults, Geriatrics
• By Application: Urinary Incontinence, Fecal Incontinence, Other Applications
• By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics

Regional Insights:

• Largest Market: North America led the market in 2023 due to the high prevalence of neurological and urological disorders.
• Fastest Growing Region: Asia-Pacific is expected to be the fastest-growing region through the forecast period, driven by increasing healthcare spending and greater adoption of non-invasive treatments.

Conclusion

The sacral nerve stimulation devices market is poised for continued growth, driven by advancements in technology, increasing awareness of non-invasive treatments, and the rising prevalence of urological disorders. Key players in the industry are focused on delivering next-generation devices that improve patient outcomes and expand access to treatment, making this an exciting time for the market.

Request A Sample Of The Global Sacral Nerve Stimulation Devices Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=18458&type=smp